-
Featured Authors
-
Archives
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Author Archive: Alan Eisenberg
Alan serves as Executive Vice President for Emerging Companies and Business Development at BIO. In this role, Alan manages and directs BIO’s services and advocacy efforts for BIO’s emerging companies, which comprise approximately 90% of BIO’s membership. This includes capital formation policy and human health policy impacting emerging companies, BIO’s portfolio of investor and partnering events globally, and BIO’s affinity purchasing program enrolling over 2000 companies.
Previously at BIO, Alan served in other senior leadership roles, including responsibilities for BIO’s communications function, as well as state government relations, Board operations, and BIO’s political action committee.
Alan holds a Master in Public Policy degree from Harvard University (Kennedy School of Government), a Master of Science in Finance degree from George Washington University, and a Bachelor of Science degree from Union College. He is married to Shalla Ross, and they have two daughters, Michayla and Isabella.Latest Posts
2011 BIO International Convention: The evolution of one-on-one partnering
From the beginning, networking has been a central focus at BIO’s events. Our members attend our conferences primarily to seek out business opportunities and to meet other biotech executives. When company presentations were introduced at the 1998 BIO International Convention, delegates registered for the conference by mail and fax and presentations were the key means for companies to tell their stories at BIO’s early events. With BIO members asking for introductions to pharmaceutical companies, BIO Read More >
